rAAVen Therapeutics is a company that creates gene therapy vectors using a unique approach called AAV peptide display. Their goal is to develop next-generation gene therapies by using their expertise in AAV engineering to design novel capsids that can precisely target specific cell populations or tissues. They offer a streamlined platform called rAAptr that utilizes nature-inspired protein-protein interactions to deliver optimized AAV products. rAAVen is dedicated to improving the lives of patients by developing innovative gene therapies and working with partners who share their vision.
Podcast creator page: http://santarovich.tilda.ws/
